TNF and myeloid sarcoma: Future studies could have particularly significant implications clinically for patients with numerous chronic autoimmune and inflammatory diseases that are distinguished by the excessive production of TNF-α but for which current anti-TNF-α treatments have been unsuccessful, such as MS.